Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Karen G. Meighen"'
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 17:223-232
Pharmacologic treatment of acute stress disorder (ASD) is a novel area of investigation across all age groups. Very few clinical drug trials have been reported in children and adolescents diagnosed with ASD. Most of the available, potentially relevan
Autor:
Judith M. Bealke, Karen G. Meighen
Publikováno v:
Psychosomatics. 46:254-258
Received June 9, 2004; revision received Oct. 16, 2004; accepted Nov. 15, 2004. From the Section of Child and Adolescent Psychiatry, Department of Psychiatry, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianap
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 14:137-142
Ziprasidone is an atypical antipsychotic that is approved for the treatment of adults with schizophrenia. To date, only a limited number of studies have been published on the use of ziprasidone for treating neuropsychiatric conditions in children and
Publikováno v:
Journal of Developmental and Physical Disabilities. 14:291-295
The efficacy of electroconvulsive therapy (ECT) as a treatment for patients with major depressive disorder who are intolerant of or refractory to antidepressant medications is well known. This treatment may be overlooked in children and adolescents,
Publikováno v:
Psychosomatics. 46(5)
Received Nov. 21, 2004; revision received Dec. 28, 2004; accepted Feb. 4, 2005. From the Section of Child and Adolescent Psychiatry, Department of Psychiatry, Indiana University School of Medicine, Bloomington; and the James Whitcomb Riley Hospital f
Autor:
Karen G. Meighen
Publikováno v:
Journal of Child & Adolescent Psychopharmacology; Feb2007, Vol. 17 Issue 1, p121-127, 7p
Publikováno v:
Journal of Child & Adolescent Psychopharmacology; 3/01/2004, Vol. 14 Issue 1, p137-142, 6p
Publikováno v:
Journal of Child & Adolescent Psychopharmacology; Apr2007, Vol. 17 Issue 2, p223-232, 1p